| Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways H Björkbacka, VV Kunjathoor, KJ Moore, S Koehn, CM Ordija, MA Lee, ... Nature medicine 10 (4), 416-421, 2004 | 817 | 2004 |
| The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades H Bjorkbacka, KA Fitzgerald, F Huet, X Li, JA Gregory, MA Lee, CM Ordija, ... Physiological Genomics 19 (3), 319-330, 2004 | 364 | 2004 |
| Gene expression in autumn leaves R Bhalerao, J Keskitalo, F Sterky, R Erlandsson, H Bjorkbacka, SJ Birve, ... Plant physiology 131 (2), 430-442, 2003 | 360 | 2003 |
| Elevated CD14++CD16− Monocytes Predict Cardiovascular Events KE Berg, I Ljungcrantz, L Andersson, C Bryngelsson, B Hedblad, ... Circulation: Cardiovascular Genetics 5 (1), 122-131, 2012 | 293 | 2012 |
| Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation I Gonçalves, A Edsfeldt, NY Ko, H Grufman, K Berg, H Björkbacka, ... Arteriosclerosis, thrombosis, and vascular biology 32 (6), 1505-1512, 2012 | 224 | 2012 |
| Malaria primes the innate immune response due to interferon-γ induced enhancement of toll-like receptor expression and function BS Franklin, P Parroche, MA Ataíde, F Lauw, C Ropert, RB de Oliveira, ... Proceedings of the National Academy of Sciences 106 (14), 5789-5794, 2009 | 219 | 2009 |
| Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide U Diczfalusy, KE Olofsson, AM Carlsson, M Gong, DT Golenbock, ... Journal of lipid research 50 (11), 2258-2264, 2009 | 212 | 2009 |
| Low levels of circulating CD4+ FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke M Wigren, H Björkbacka, L Andersson, I Ljungcrantz, GN Fredrikson, ... Arteriosclerosis, thrombosis, and vascular biology 32 (8), 2000-2004, 2012 | 192 | 2012 |
| T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke D Engelbertsen, L Andersson, I Ljungcrantz, M Wigren, B Hedblad, ... Arteriosclerosis, thrombosis, and vascular biology 33 (3), 637-644, 2013 | 139 | 2013 |
| Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL S Elsøe, J Ahnström, C Christoffersen, AN Hoofnagle, P Plomgaard, ... Atherosclerosis 221 (1), 91-97, 2012 | 134 | 2012 |
| Multiple roles of Toll-like receptor signaling in atherosclerosis H Björkbacka Current opinion in lipidology 17 (5), 527-533, 2006 | 134 | 2006 |
| Elevated plasma levels of MMP-12 are associated with atherosclerotic burden and symptomatic cardiovascular disease in subjects with type 2 diabetes I Goncalves, E Bengtsson, HM Colhoun, AC Shore, C Palombo, A Natali, ... Arteriosclerosis, thrombosis, and vascular biology 35 (7), 1723-1731, 2015 | 123 | 2015 |
| Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine M Wigren, D Kolbus, P Dunér, I Ljungcrantz, I Söderberg, H Björkbacka, ... Journal of internal medicine 269 (5), 546-556, 2011 | 123 | 2011 |
| Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaques L Tomas, A Edsfeldt, IG Mollet, L Perisic Matic, C Prehn, J Adamski, ... European heart journal 39 (24), 2301-2310, 2018 | 121 | 2018 |
| Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B‐100 transgenic mice without inducing an increase in peptide‐specific antibodies GN Fredrikson, H Björkbacka, I Söderberg, I Ljungcrantz, J Nilsson Journal of internal medicine 264 (6), 563-570, 2008 | 120 | 2008 |
| CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe-/- mice D Kolbus, OH Ramos, KE Berg, J Persson, M Wigren, H Björkbacka, ... BMC immunology 11, 1-14, 2010 | 114 | 2010 |
| Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals OS Cotoi, P Dunér, N Ko, B Hedblad, J Nilsson, H Björkbacka, A Schiopu Arteriosclerosis, thrombosis, and vascular biology 34 (1), 202-210, 2014 | 113 | 2014 |
| Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque A Edsfeldt, M Nitulescu, H Grufman, C Grönberg, A Persson, M Nilsson, ... Stroke 43 (12), 3305-3312, 2012 | 110 | 2012 |
| Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study M Persson, G Engström, H Björkbacka, B Hedblad Atherosclerosis 220 (2), 502-505, 2012 | 106 | 2012 |
| Circulating monocyte chemoattractant protein-1 and risk of stroke: meta-analysis of population-based studies involving 17 180 individuals MK Georgakis, R Malik, H Björkbacka, TA Pana, S Demissie, C Ayers, ... Circulation research 125 (8), 773-782, 2019 | 101 | 2019 |
Jan NilssonProfessor of Experimental Cardiovascular Research, Lund UniversityVerified email at med.lu.se
